Bokf Na lifted its stake in shares of Colgate-Palmolive (NYSE: CL – Get Rating) by 0.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 82,929 shares of the company stock after buying an additional 211 shares during the quarter. Bokf Na’s holdings in Colgate-Palmolive were worth $ 7,078,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds and other institutional investors also recently made changes to their positions in CL. Horan Securities Inc. purchased a new stake in Colgate-Palmolive in the fourth quarter worth about $ 30,000. Fortis Advisors LLC purchased a new stake in Colgate-Palmolive in the third quarter worth about $ 38,000. TAP Consulting LLC purchased a new stake in Colgate-Palmolive in the fourth quarter worth about $ 40,000. Widmann Financial Services Inc. purchased a new stake in Colgate-Palmolive in the fourth quarter worth about $ 42,000. Finally, Industrial Alliance Investment Management Inc. purchased a new stake in Colgate-Palmolive in the fourth quarter worth about $ 42,000. Institutional investors own 78.12% of the company stock.
In related news, CEO Noel R. Wallace sold 50,000 shares of the firm’s stock in a transaction on Monday, June 6th. The shares were sold at an average price of $ 79.34, for a total transaction of $ 3,967,000.00. Following the completion of the transaction, the chief executive officer now directly owns 221,790 shares of the company stock, valued at $ 17,596,818.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Philip G. Shotts sold 10,000 shares of the firm’s stock in a transaction on Monday, May 16th. The shares were sold at an average price of $ 78.52, for a total transaction of $ 785,200.00. Following the transaction, the vice president now directly owns 46,094 shares of the company stock, valued at $ 3,619,300.88. The disclosure for this sale can be found here. Over the last three months, insiders sold 79,683 shares of company stock valued at $ 6,297,119. Corporate insiders own 0.32% of the company stock.
A number of equities research analysts have weighed in on CL shares. StockNews.com cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Wednesday, April 13th. Raymond James assumed coverage on shares of Colgate-Palmolive in a report on Thursday, April 7th. They set a “market perform” rating on the stock. Stifel Nicolaus cut their price target on shares of Colgate-Palmolive from $ 90.00 to $ 88.00 in a report on Wednesday, April 13th. JPMorgan Chase & Co. cut their price target on shares of Colgate-Palmolive from $ 86.00 to $ 81.00 and set a “neutral” rating on the stock in a report on Wednesday, March 30th. Finally, Atlantic Securities downgraded shares of Colgate-Palmolive from an “overweight” rating to a “neutral” rating and lowered their price target for the company from $ 92.00 to $ 80.00 in a research report on Tuesday, May 3rd. One research analyst has rated the stock with a sell rating, thirteen have given a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Hold” and an average price target of $ 85.40.
CL opened at $ 74.04 on Friday. The company has a current ratio of 1.09, a quick ratio of 0.67 and a debt-to-equity ratio of 10.42. Colgate-Palmolive has a 1-year low of $ 72.20 and a 1-year high of $ 85.61. The company has a market capitalization of $ 62.04 billion, a PE ratio of 30.60, a PEG ratio of 5.00 and a beta of 0.56. The firm’s 50 day simple moving average is $ 78.11 and its two-hundred day simple moving average is $ 79.12.
Colgate-Palmolive (NYSE: CL – Get Rating) last announced its quarterly earnings data on Friday, April 29th. The company reported $ 0.74 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $ 0.74. The firm had revenue of $ 4.40 billion during the quarter, compared to analysts’ expectations of $ 4.40 billion. Colgate-Palmolive had a net margin of 11.70% and a return on equity of 296.77%. The company revenue for the quarter was up 1.3% compared to the same quarter last year. During the same period in the prior year, the company posted $ 0.80 earnings per share. Equities analysts forecast that Colgate-Palmolive will post 3.05 earnings per share for the current fiscal year.
Colgate-Palmolive declared that its board has authorized a stock buyback plan on Thursday, March 10th that authorizes the company to buyback $ 5.00 billion in shares. This buyback authorization authorizes the company to purchase up to 8.1% of its shares through open market purchases. Shares buyback plans are typically a sign that the company board believes its stock is undervalued.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, August 15th. Stockholders of record on Thursday, July 21st will be paid a $ 0.47 dividend. The ex-dividend date is Wednesday, July 20th. This represents a $ 1.88 dividend on an annualized basis and a dividend yield of 2.54%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 77.69%.
Colgate-Palmolive Profile: (Get Rating)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Read More:
Receive News & Ratings for Colgate-Palmolive Daily: – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Colgate-Palmolive and related companies with MarketBeat.com’s FREE daily email newsletter.
.